Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.51 |
| ▸ | TP53 | P04637 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 3/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.48 |
| ▸ | FEN1 | P39748 | 12/20 | 0.43 |
| ▸ | ALOX5AP | P20292 | 11/20 | 0.43 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | APP | P05067 | 1/20 | 0.39 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.38 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.38 |
| ▸ | NPBWR1 | P48145 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18979181 | 0.95 | HSD11B1 (0.50) | MAPTTP53GAAPOLBHSD11B1 | |
| SCHEMBL19219730 | 0.81 | MAPT (0.48) | MAPTTP53GAAPOLBFEN1 | |
| SCHEMBL19219734 | 0.80 | TP53 (0.47) | MAPTTP53GAAPOLBFEN1 | |
| SCHEMBL30843064 | 0.77 | MAPT (0.50) | MAPTTP53GAAPOLBFEN1 | |
| SCHEMBL30843112 | 0.77 | TP53 (0.46) | MAPTTP53GAAPOLBFEN1 | |
| SCHEMBL18979134 | 0.76 | TP53 (0.45) | MAPTTP53GAAPOLBHSD11B1 | |
| SCHEMBL19219732 | 0.75 | HSD11B1 (0.41) | MAPTTP53GAAPOLBHSD11B1 | |
| SCHEMBL18751256 | 0.75 | TP53 (0.44) | MAPTTP53GAAPOLBFEN1 | |
| SCHEMBL15426486 | 0.71 | HSD11B1 (0.47) | POLBHSD11B1FEN1ALOX5APCYP1A2 | |
| SCHEMBL15426497 | 0.70 | HSD11B1 (0.49) | HSD11B1NPBWR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220000112-A1 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| US-10021880-B2 | Diarylimidazole compound and harmful organism control agent | NIPPON SODA CO., LTD. (JP) | 2018-07-17 | — | — | US | disclosed |
| US-20170223958-A1 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2017-08-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10021880-B2 | Diarylimidazole compound and harmful organism control agent | NOX1, L3MBTL1, MRM1 | MAPT 4473/4885TP53 3609/4885GAA 3504/4885 |
| US-20220000112-A1 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NOX1, L3MBTL1, MRM1 | MAPT 4473/4885TP53 3609/4885GAA 3504/4885 |
| US-20170223958-A1 | DIARYLIMIDAZOLE COMPOUND AND HARMFUL ORGANISM CONTROL AGENT | NOX1, L3MBTL1, MRM1 | MAPT 4473/4885TP53 3609/4885GAA 3504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.